Tyrosine Protein Kinases: The Insulin Receptor Example
The insulin receptor is a classic example of a catalytic receptor. It is a tetramer composed of four subunits:
- Two $\alpha$-subunits: located extracellularly. Their N-terminal domains form the hormone-binding site.
- Two $\beta$-subunits: span the membrane (transmembrane domains). Their intracellular portions contain tyrosine residues and possess catalytic (tyrosine kinase) activity.
When an insulin molecule binds to the $\alpha$-subunits, cooperative conformational changes occur, activating the tyrosine kinase in the $\beta$-subunits. This initiates transautophosphorylation: one $\beta$-subunit phosphorylates the other at tyrosine residues using high-energy bonds from ATP (converting ATP to ADP).
As a result, the charge, conformation, and substrate specificity of the enzyme change. The active receptor phosphorylates insulin receptor substrate 1 (IRS-1). This protein acts as a key adaptor; if its structure is impaired, signal transduction is blocked. Next, IRS-1 binds to PI3-kinase, leading to the production of PIP3 and the activation of protein kinase B (Akt/PKB).
Cellular Effects of Insulin Receptor Activation
The triggered intracellular cascade leads to three main groups of effects:
- Metabolic Regulation (Enzyme Activation)
Phosphodiesterase is activated, which converts cAMP to AMP and cGMP to GMP, lowering the levels of these secondary messengers (this inhibits glycogenolysis and lipolysis). Phosphoprotein phosphatases are also activated, dephosphorylating metabolic enzymes (e.g., activating glycogen synthase to store glucose). To turn off the signal itself, a specific tyrosine protein phosphatase dephosphorylates the receptor's $\beta$-subunits.
- Glucose Transport
In insulin-dependent tissues (muscle and adipose tissue), the translocation of GLUT-4 transporter proteins from the cytosol to the plasma membrane is stimulated, facilitating glucose entry into the cell.
- Genomic Effects
The signal is transmitted to nuclear regulatory proteins and transcription factors, repressing the synthesis and promoting the degradation of certain enzymes while inducing the synthesis of anabolic enzymes (protein, lipid, and glycogen synthesis).
Growth Factor Receptors
In their inactive state, these receptors consist of a single polypeptide chain containing a glycosylated extracellular domain, a transmembrane domain ($\alpha$-helix), and a cytoplasmic domain with protein kinase activity.
Upon binding a primary messenger (growth factor), the receptors pair up to form dimers. Dimerization activates the intracellular domains, followed by transautophosphorylation at serine, threonine, or tyrosine residues. The resulting phosphorylated residues serve as docking sites for specific cytosolic proteins, initiating downstream protein kinase cascades.
Receptors with Guanylyl Cyclase Activity
These receptors represent membrane-bound guanylyl cyclase (GC), a transmembrane glycoprotein. The extracellular domain binds the hormone, while the intracellular domain exhibits catalytic activity.
A physiological example of such a ligand is atrial natriuretic peptide (ANP), which regulates fluid homeostasis in the body.
Signal Transduction Mechanism:
- Hormone binding activates guanylyl cyclase.
- The enzyme catalyzes the formation of cyclic guanosine-3',5'-monophosphate (cGMP) from GTP.
- cGMP molecules bind to the regulatory sites of protein kinase G (PKG). Exactly 4 cGMP molecules are required to alter the conformation and activate this enzyme.
- Active PKG phosphorylates specific cytosolic proteins and enzymes, transferring a phosphate group from ATP to the target protein.